Journal of Antimicrobial Chemotherapy, Vol 39, 199-207, Copyright © 1997 by The British Society for Antimicrobial Chemotherapy
G Candiani, M Abbondi, M Borgonovi and R Williams
Lobar pneumonia models were established in rats by intratracheal
inoculation of either penicillin-susceptible (immunocompetent model) or
penicillin-resistant (immunocompetent and neutropenic models) Streptococcus
pneumoniae. Untreated animals maintained a relatively high bacterial load
in the lungs but only occasionally developed bacteraemia or pleurisy. The
infection was rarely fatal in immunocompetent rats, but immunocompromised
rats frequently died. Treatment i.m. with 10,000 IU/kg of procaine
penicillin G (12 h after infection then bid for 3 days) or with a single
i.v. dose of 5 or 10 mg/kg of teicoplanin significantly reduced lung
bacterial loads of rats infected with the penicillin-susceptible strain.
Against the penicillin- resistant strain, teicoplanin displayed a
significant activity regardless of the immununological status of the
animals. Penicillin G significantly reduced lung bacterial load of the
penicillin-resistant strain only in immunocompetent rats and at a higher
dose than needed in treatment of the penicillin-susceptible infection. The
experimental models described here could be suitable for studying the
efficacy of antibacterial agents against pulmonary infections caused by
penicillin- susceptible and penicillin-resistant S. pneumoniae strains.
JOURNAL ARTICLE
Experimental lobar pneumonia due to penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae in immunocompetent and neutropenic rats: efficacy of penicillin and teicoplanin treatment
Lepetit Research Center, Hoechst Marion Roussel, Gerenzano (Varese), Italy.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
D. Chiavolini, G. Pozzi, and S. Ricci Animal Models of Streptococcus pneumoniae Disease Clin. Microbiol. Rev., October 1, 2008; 21(4): 666 - 685. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Prass, J. S. Braun, U. Dirnagl, C. Meisel, and A. Meisel Stroke Propagates Bacterial Aspiration to Pneumonia in a Model of Cerebral Ischemia Stroke, October 1, 2006; 37(10): 2607 - 2612. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Piroth, L. Martin, A. Coulon, C. Lequeu, M. Duong, M. Buisson, H. Portier, and P. Chavanet Development of a New Experimental Model of Penicillin-Resistant Streptococcus pneumoniae Pneumonia and Amoxicillin Treatment by Reproducing Human Pharmacokinetics Antimicrob. Agents Chemother., October 1, 1999; 43(10): 2484 - 2492. [Abstract] [Full Text] |
||||
![]() |
G. Candiani, M. Abbondi, M. Borgonovi, G. Romano, and F. Parenti In-vitro and in-vivo antibacterial activity of BI 397, a new semi-synthetic glycopeptide antibiotic J. Antimicrob. Chemother., August 1, 1999; 44(2): 179 - 192. [Abstract] [Full Text] [PDF] |
||||



